Weixinkang medicine - Innovation Achievement

The company has obtained a total of 12 national invention patents, 16 new drug certificates and helped the business partners acquire 59 approved drug registration approvals under the company's technical support. After purchasing Inner Mongolia Baiyi Pharmaceutical Co., Ltd. in 2012, the company has independently researched and developed 28 projects of new products. The potassium aspartate injection obtained the drug approval number in 2015. The company's main production lines have all passed the new GMP certification, namely the lines of the large-volume injection, small-volume injection for terminal sterilization, small-volume injection for non-terminal sterilization, and freeze-dried powder injection.